191
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
Condition(s):Prostate Cancer MetastaticLast Updated:March 15, 2021Completed
Prostate Cancer Metastatic: 1673 Clinical Trials, Page 20 of 168
Hide Studies Not Open or Pending
192
Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)
Condition(s):Circulating Tumor Cell; Metastatic Prostate CancerLast Updated:July 5, 2019Recruiting
193
[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer
Condition(s):Metastatic Prostate CancerLast Updated:March 4, 2021Recruiting
194
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
Condition(s):Prostatic CancerLast Updated:April 11, 2013Completed
195
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Condition(s):Metastatic Hormone-sensitive Prostate CancerLast Updated:October 27, 2020Active, not recruiting
196
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
Condition(s):Prostatic NeoplasmsLast Updated:April 20, 2018Completed
197
Post-eRADicAte – A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)
Condition(s):Prostate Cancer MetastaticLast Updated:March 19, 2019Active, not recruiting
198
Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
Condition(s):Metastatic Prostate CancerLast Updated:September 10, 2007Unknown status
199
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Condition(s):Prostate CancerLast Updated:June 25, 2020Active, not recruiting
200
Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone
Condition(s):Prostate Cancer Metastatic to BoneLast Updated:January 13, 2021Recruiting